Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer

Detalles Bibliográficos
Autores principales: Cortés-Funes, H, Mendiola, C, Manso, L, Ciruelos, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284883/
http://dx.doi.org/10.1186/bcr2280
_version_ 1782351484263858176
author Cortés-Funes, H
Mendiola, C
Manso, L
Ciruelos, E
author_facet Cortés-Funes, H
Mendiola, C
Manso, L
Ciruelos, E
author_sort Cortés-Funes, H
collection PubMed
description
format Online
Article
Text
id pubmed-4284883
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42848832015-01-15 Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer Cortés-Funes, H Mendiola, C Manso, L Ciruelos, E Breast Cancer Res Oral Presentation BioMed Central 2009 2009-06-23 /pmc/articles/PMC4284883/ http://dx.doi.org/10.1186/bcr2280 Text en Copyright © 2009 BioMed Central Ltd.
spellingShingle Oral Presentation
Cortés-Funes, H
Mendiola, C
Manso, L
Ciruelos, E
Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer
title Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer
title_full Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer
title_fullStr Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer
title_full_unstemmed Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer
title_short Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer
title_sort neratinib, an irreversible pan erb receptor tyrosine kinase inhibitor active for advanced her2(+ )breast cancer
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284883/
http://dx.doi.org/10.1186/bcr2280
work_keys_str_mv AT cortesfunesh neratinibanirreversiblepanerbreceptortyrosinekinaseinhibitoractiveforadvancedher2breastcancer
AT mendiolac neratinibanirreversiblepanerbreceptortyrosinekinaseinhibitoractiveforadvancedher2breastcancer
AT mansol neratinibanirreversiblepanerbreceptortyrosinekinaseinhibitoractiveforadvancedher2breastcancer
AT ciruelose neratinibanirreversiblepanerbreceptortyrosinekinaseinhibitoractiveforadvancedher2breastcancer

Ejemplares similares